In present study, we provided new evidence that TRIM52 expression was elevated in CRC tissues (Fig. 1a) and cell lines (Fig. 2a), and that TRIM52 expression was significantly correlated with tumor size, tumor stage and overall survival of CRC patients (Fig. 1b and Table 2). The gene discussed is TRIM52; the disease is neoplasm.